This website uses cookies to function correctly.
You may delete cookies at any time but doing so may result in some parts of the site not working correctly.

Patient Alerts


The MHRA is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. The MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC), (external link)  and the Clinical practice Research Datalink (CPRD). (external link) The MHRA is an executive agency of the Department of Health.



The Central Alerting System (CAS) is a web-based cascading system for issuing patient safety alerts, important public health messages and other safety critical information and guidance to the NHS and others, including independent providers of health and social care.

Both of these agencies issue alerts with regards to medical equipment, health issues and general information on patient health.


St Johns Wort - The Herbal Research Company Ltd is recalling six batches of St John's Wort tablets as testing has shown the presence of a toxic pyrrolizidine alkaloid (PA) above the threshold recommended by the Committeee on Herbal Medicinal Products (HMPC). Please click here for further information (Febuary 2016)

Owen Mumford Insulin Autopens - Risk of hyperglyceaemia, which could lead to immediate and long-term detrioration of health.  Affected devices may have a mechanical fault which could casuse the dose selector to revert to zero resulting in the devices not delivering the correct dose of insulin. Please click here for further information (December 2014)

 Recall of Zovirax Eye Ointment - GlaxoSmithKline UK is recalling certain batches of Zovirax Eye Ointment as a precaution because the batches of active pharmaceutical ingredient used in their manufacture were found to contain metal particles which were outside the upper specification limit for particle size. No complaints or adverse reaction reports relating to this issue have been received by the company to date. Please click here for further information (November 2014)

Recall of Fybogel High Fibre and Orange - Reckitt Benckiser Healthcare (UK) Limited is recalling a further two batches of Fybogel due to a potential risk of contamination with metal particles. Please click here for further information (July 2014) 

E-cigarettes, Batteries and Chargers - An alert has been issued regarding the potential for fire or explosion during recharging the battery in an oxygen rich environment. This does not affect disposible E Cigarettes.  Please click here for further information. 

Accu-Chek Mobile meter and Accu-Chek Mobile test cassette manufactured by Roche -  This device may give falsely high reading.  As a consequence, patients might take an inappropriately high dose of insulin. Please click here for further information.



Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website